— Know what they know.
Not Investment Advice

SAGD OTC

South American Gold Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +900.0% 1Y: +900.0% 3Y: -50.0% 5Y: -83.3%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 51 · $67735 mcap · 672M float · 0.0001% daily turnover · Short 55% of daily vol

Income Trends

Revenue
$20K +144.2% ▲
Gross Profit
$20K +144.2% ▲
Operating Income
-$10K +84.9% ▲
Net Income
-$119K +4.7% ▲
EPS (Diluted)
$-0.00 +0.0% ▲
EBITDA
-$78K +37.9% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2013FY2014FY2015FY2016FY2017
Revenue$0$8K$26K$8K$20K
YoY Growth+0.0%+0.0%+240.0%-68.3%+144.2%
Cost of Revenue$125$0$0$0$0
Gross Profit-$125$0$26K$8K$20K
Gross Margin—0.0%100.0%100.0%100.0%
R&D Expenses$0$0$0$0$0
SG&A Expenses$111K$82K$124K$71K$30K
Operating Expenses$111K$82K$124K$71K$30K
Operating Income-$112K-$75K-$98K-$63K-$10K
Operating Margin—-983.0%-378.1%-772.2%-47.7%
Interest Expense$74K$107K$107K$0$42K
Income Before Tax-$206K-$259K-$339K-$125K-$119K
Tax Expense$0$0$0$0$0
Net Income-$206K-$259K-$339K-$125K-$119K
Net Margin—-3407.9%-1311.9%-1525.2%-595.3%
EPS (Diluted)$-0.92$-0.32$-0.00$-0.00$-0.00
EBITDA-$131K-$152K-$232K-$125K-$78K
Shares Outstanding224996824996108M652M668M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms